The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer

American Journal of Psychiatry

Volumn 171, Issue 10, 2014, Pages 1067-1073

  Viktorin, Alexander ^a   Lichtenstein, Paul ^a   Thase, Michael E ^a   Larsson, Henrik ^a   Lundholm, Cecilia ^a   Magnusson, Patrik K E ^a   Landén, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MOOD STABILIZER; NORTRIPTYLINE; PAROXETINE; SERTRALINE; TRIMIPRAMINE; VALPROIC ACID; VENLAFAXINE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; DISEASE REGISTRY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MONOTHERAPY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TREATMENT DURATION; AFFECT; CHEMICALLY INDUCED; COMPLICATION; DRUG COMBINATION; DRUG EFFECTS; REGISTER; YOUNG ADULT;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS; REGISTRIES; YOUNG ADULT;

EID: 84907486027     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.13111501     Document Type: Article

References (33)

1. Thase ME: Bipolar depression: diagnostic and treatment considerations. Dev Psychopathol 2006; 18:1213-1230
2. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB: A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60:261-269
3. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530-537
4. Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE Jr, McElroy SL, Grunze H, Post RM: Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 2007; 9:531-535
5. López P, Mosquera F, de León J, Gutiérrez M, Ezcurra J, Ramírez F, González-Pinto A: Suicide attempts in bipolar patients. J Clin Psychiatry 2001; 62:963-966
6. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Leon AC, Solomon DA, Coryell W, Maser JD, Keller MB: Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry 2005; 62:1322-1330
7. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J: Patterns of psychotropic drug prescription for US patients with diagnoses of bipolar disorders. Psychiatr Serv 2007; 58:85-91
8. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361:653-661
9. Maj M, Pirozzi R, Magliano L, Bartoli L: The prognostic significance of "switching" in patients with bipolar disorder: a 10-year prospective follow-up study. Am J Psychiatry 2002; 159:1711-1717
10. Wehr TA, Goodwin FK: Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36:555-559
11. Ball JR, Kiloh LG: A controlled trial of imipramine in treatment of depressive states. BMJ 1959; 2:1052-1055
12. Leyberg JT, Denmark JC: The treatment of depressive states with imipramine hydrochloride (Tofranil). J Ment Sci 1959; 105:1123-1126
13. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L: Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152:1130-1138
14. Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL: Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998; 59:374-379
15. Peet M: Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164:549-550
16. Prien RF, Klett CJ, Caffey EM Jr: Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973; 29:420-425
17. Truman CJ, Goldberg JF, Ghaemi SN, Baldassano CF, Wisniewski SR, Dennehy EB, Thase ME, Sachs GS: Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 2007; 68:1472-1479
18. Valentí M, Pacchiarotti I, Bonnín CM, Rosa AR, Popovic D, Nivoli AM, Goikolea JM, Murru A, Undurraga J, Colom F, Vieta E: Risk factors for antidepressant-related switch to mania. J Clin Psychiatry 2012; 73:e271-e276
19. Angst J: Switch from depression to mania: a record study over decades between 1920 and 1982. Psychopathology 1985; 18:140-154
20. Lewis JL, Winokur G: The induction of mania: a natural history study with controls. Arch Gen Psychiatry 1982; 39:303-306
21. Visser HM, Van Der Mast RC: Bipolar disorder, antidepressants, and induction of hypomania or mania: a systematic review. World J Biol Psychiatry 2005; 6:231-241
22. Nivoli AM, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A, Fountoulakis KN, Vieta E: New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord 2011; 129:14-26
23. Bottlender R, Rudolf D, Strauss A, Möller HJ: Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J Affect Disord 2001; 63:79-83
24. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M: Antidepressant-induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 2001; 62:249-255
25. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM: Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006; 163:232-239
26. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I: Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157:124-126
27. Tondo L, Vázquez G, Baldessarini RJ: Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand 2010; 121:404-414
28. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A: The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24:659-667
29. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO: External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11:450
30. Sellgren C, Landén M, Lichtenstein P, Hultman CM, La˚ngström N: Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden. Acta Psychiatr Scand 2011; 124:447-453
31. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M: The new Swedish Prescribed Drug Register: opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16:726-735
32. Goldberg JF, Truman CJ: Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003; 5:407-420
33. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E: The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; 170:1249-1262